Cargando…
Initial exploration of a novel fusion protein, IL-4/IL-34/IL-10, which promotes cardiac allograft survival mice through alloregulation
Immune mediated graft loss still represents a major risk to transplant recipients. Creative approaches to immunosuppression that exploit the recipient's own alloregulatory mechanisms could reduce the need for pharmacologic immunosuppression and potentially induce immune tolerance. In the proces...
Autores principales: | Lee, Young S., Cheng, I-Ting, Raquel, Godoy-Ruiz, Weber, David J., Scalea, Joseph R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559875/ https://www.ncbi.nlm.nih.gov/pubmed/37800911 http://dx.doi.org/10.1177/17534259231186239 |
Ejemplares similares
-
IL-32 and IL-34 in hepatocellular carcinoma
por: Si, Yang, et al.
Publicado: (2022) -
IL‐10 producing type 2 innate lymphoid cells prolong islet allograft survival
por: Huang, Qingsong, et al.
Publicado: (2020) -
The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis
por: Sternby, Hanna, et al.
Publicado: (2021) -
The role of IL-31 and IL-34 in the diagnosis and treatment of chronic periodontitis
por: Luo, Ying, et al.
Publicado: (2023) -
Assessment of Interleukins IL-4, IL-6, IL-8, IL-10 in Acute Urticaria
por: Papadopoulos, Jordan, et al.
Publicado: (2014)